Key facts
- This page summarizes Regina M. Benjamin's Form 4 filing for Oak Street Health, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 May 2023, 20:01.
Regina M. Benjamin - 02 May 2023 Form 4 Insider Report for Oak Street Health, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 02 May 2023
- Net transaction value
- -$931,359
- SEC form
- 4
- Accepted by SEC
- 02 May 2023, 20:01:41 UTC
- Prior SEC filing
- 25 Apr 2023
- Next SEC filing
- 28 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Guenthner, attorney-in-fact for Regina M. Benjamin
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Regina M. Benjamin filed Form 4 for Oak Street Health, Inc. on 02 May 2023.
Change
- Previous filing in this sequence was filed on 25 Apr 2023.
- Current net transaction value: -$931,359.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OSH
transaction
Common stock, $0.001 par value
Disposed to Issuer
- Transaction value
- $931,359
- Shares
- -23,881
- Change %
- -100%
- Price
- $39.00
- Shares after
- 0
- Date
- 02 May 2023
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Regina M. Benjamin is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
Pursuant to that certain Agreement and Plan of Merger, dated as of February 7, 2023 (the "Merger Agreement"), by and among the Issuer, CVS Pharmacy, Inc. ("Parent"), Halo Merger Sub Corp. ("Merger Sub") and, for the limited purposes set forth therein, CVS Health Corporation, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $39.00 per share in cash, without interest and subject to applicable tax withholdings (the "Per Share Price").
Footnote F2
(Continued from Footnote 1) The shares of the Issuer's common stock reported as disposed by the Reporting Person include vested restricted stock units ("RSUs") of the Issuer which, pursuant to the Merger Agreement, were, at the Effective Time, automatically canceled and converted into the right to receive an amount in cash (without interest and subject to applicable tax withholdings) equal to the product of the Per Share Price multiplied by the number of shares of the Issuer's common stock subject to such RSUs as of immediately prior to the Effective Time.
Footnote F3
The shares of the Issuer's common stock reported as disposed on this Form 4 reflects a correction to the Reporting Person's Form 4 filed on October 15, 2020, which inadvertently reported an issuance of 3,912 RSUs to the Reporting Person rather than an issuance of 3,921 RSUs to the Reporting Person, resulting in the Reporting Person's beneficial ownership of the Issuer's common stock being understated by 9 shares.